ID   B207
AC   CVCL_WM86
DR   CCTCC; GDC0222
DR   Wikidata; Q93328310
RX   Patent=US6339143;
RX   PubMed=10451222;
RX   PubMed=12850278;
CC   Group: Patented cell line.
CC   Registration: International Depositary Authority, American Type Culture Collection (ATCC); PTA-1626.
CC   Monoclonal antibody isotype: Not specified.
CC   Monoclonal antibody target: UniProtKB; P0DN86; Human CGB (Note=Also recognizes LHB).
OX   NCBI_TaxID=10090; ! Mus musculus (Mouse)
HI   CVCL_4032 ! P3X63Ag8.653
CA   Hybridoma
DT   Created: 24-05-19; Last updated: 02-05-24; Version: 8
//
RX   Patent=US6339143;
RA   Krichevsky A., Birken S., O'Connor J., Canfield R.E.;
RT   "Methods of using antibodies against hormone-related determinants.";
RL   Patent number US6339143, 15-Jan-2002.
//
RX   PubMed=10451222; DOI=10.1385/ENDO:10:2:137;
RA   Birken S., Krichevsky A., O'Connor J., Schlatterer J., Cole L.,
RA   Kardana A., Canfield R.E.;
RT   "Development and characterization of antibodies to a nicked and
RT   hyperglycosylated form of hCG from a choriocarcinoma patient:
RT   generation of antibodies that differentiate between pregnancy hCG and
RT   choriocarcinoma hCG.";
RL   Endocrine 10:137-144(1999).
//
RX   PubMed=12850278; DOI=10.1016/S0303-7207(03)00153-9;
RA   Birken S., Yershova O., Myers R.V., Bernard M.P., Moyle W.;
RT   "Analysis of human choriogonadotropin core 2 o-glycan isoforms.";
RL   Mol. Cell. Endocrinol. 204:21-30(2003).
//